Dewan Md. Sumsuzzman

Dr. Dewan Md. Sumsuzzman

Mathematics and Statistics, York University, Toronto, Ontario, Canada
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
YYYang Ye
Yang Ye
APAbhishek Pandey
Abhishek Pandey
CBCarolyn Bawden
Carolyn Bawden
Dewan Md. SumsuzzmanDewan Md. Sumsuzzman
Dewan Md. Sumsuzzman
RRRimpi Rajput
Rimpi Rajput
AGAlison P. Galvani
Alison P. Galvani
Integrating prior epidemiological knowledge embedded within mechanistic models with the data-mining capabilities of artificial intelligence (AI) offers transformative potential for epidemiological modeling. While the fusion of AI and traditional mechanistic approaches is rapidly advancing, efforts remain fragmented. This scoping review provides a comprehensive overview of emerging integrated models applied across the spectrum of infectious diseases. Through systematic search strategies, we identified 245 eligible studies from 15,460 records. Our review highlights the practical value of integrated models, including advances in disease forecasting, model parameterization, and calibration. However, key research gaps remain. These include the need for better incorporation of realistic decision-making considerations, expanded exploration of diverse datasets, and further investigation into biological and socio-behavioral mechanisms. Addressing these gaps will unlock the synergistic potential of AI and mechanistic modeling to enhance understanding of disease dynamics and support more effective public health planning and response.

1 August 2021 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Open access
Dewan Md. SumsuzzmanDewan Md. Sumsuzzman
Dewan Md. Sumsuzzman
Jeonghyun ChoiJeonghyun Choi
Jeonghyun Choi
YJYunho Jin
Yunho Jin
Yonggeun HongYonggeun Hong
Yonggeun Hong
Endogenous melatonin levels are inversely associated with age and cognitive deficits. Although melatonin can improve psychopathological behavior disturbances in clinical trials, whether melatonin may also enhance cognitive function remains elusive. This study examined cognitive outcomes from randomized trials of melatonin treatment for Alzheimer's disease (AD), insomnia, and healthy-subjects. Twenty-two studies met the inclusion criteria (AD = 9, insomnia = 2, healthy-subjects = 11). AD patients receiving >12 weeks of melatonin treatment improved mini-mental state examination (MMSE) score [MD: 1.82 (1.01; 2.63) p < 0.0001]. Importantly, melatonin significantly improved MMSE score in mild stage of AD [MD: 1.89 (0.96; 2.82) p < 0.0001]. In healthy-subjects, although daytime melatonin treatment notably decreased in accuracy by correct responses [SMD: -0.74 (-1.03; -0.45) p < 0.00001], the reaction-time score on different stimuli (p = 0.37) did not increased. Additionally, by pooling of short-term, spatial, and visual memory scores, melatonin did not reduce memory function (p = 0.08). Meta-analysis of MMSE score suggested that melatonin is effective in treatment for mild stage of AD. Additionally, we propose that melatonin may be preferable to traditional hypnotics in management of insomnia.

17 June 2019 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
FHFarhad Hossain
Farhad Hossain
SUSahab Uddin
Sahab Uddin
GUG. M. Sala Uddin
G. M. Sala Uddin
Dewan Md. SumsuzzmanDewan Md. Sumsuzzman
Dewan Md. Sumsuzzman
SISiddiqul Islam
Siddiqul Islam
Ghulam M. AshrafGhulam M. Ashraf
Ghulam M. Ashraf

1 May 2025 in The Lancet Child & Adolescent Health
Verified
Journal Article
Closed access
Dewan Md. SumsuzzmanDewan Md. Sumsuzzman
Dewan Md. Sumsuzzman
ZWZhen Wang
Zhen Wang
JLJoanne M Langley
Joanne M Langley
SMSeyed M Moghadas
Seyed M Moghadas

7 December 2018 in Molecules
Verified
Journal Article
Open access
PDF file
YJYunho Jin
Yunho Jin
Dewan Md. SumsuzzmanDewan Md. Sumsuzzman
Dewan Md. Sumsuzzman
Jeonghyun ChoiJeonghyun Choi
Jeonghyun Choi
HKHyunbon Kang
Hyunbon Kang
SLSang-rae Lee
Sang-rae Lee
Yonggeun HongYonggeun Hong
Yonggeun Hong
Irisin, a skeletal muscle-secreted myokine, produced in response to physical exercise, has protective functions in both the central and the peripheral nervous systems, including the regulation of brain-derived neurotrophic factors. In particular, irisin is capable of protecting hippocampus. Since this area is the region of the brain that is most susceptible to Alzheimer’s disease (AD), such beneficial effect may inhibit or delay the emergence of neurodegenerative diseases, including AD. Also, the factors engaged in irisin formation appear to suppress Aβ aggregation, which is the pathological hallmark of AD. This review is based on the hypothesis that irisin produced by physical exercise helps to control AD progression. Herein, we describe the physiology of irisin and its potential role in delaying or preventing AD progression in human.